- Home
- Industry Reports
- Diagnostics
- Healthcare
- Mexico In Vitro Diagnostics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
An in-vitro diagnostic is a process where diagnostic tests performed using analytical instruments and reagents on specific samples such as blood, urine, and other body fluids. The samples are gathered from patients or healthy individuals to identify and detect the diseases. The market is valued at USD XX billion in 2017 and is projected to USD XX billion by 2024 at a CAGR of 5.8%.
Mexico In-Vitro Diagnostics Market Share:
IVD plays a vital role in early diagnostics and detection of diseases. The point of care testing segment is holding the most significant share in the market at present.
Mexico In-Vitro Diagnostics Market Size:
North America is the leading one, and Mexico is expected to grow and dominate in forecast due to increasing acceptance of personalised medicine and growing adoption of advanced products and increase in chronic diseases patient pool and technological advancements. Asia-Pacific is expected to have highest CAGR during forecast due to growth in research and increasing investments.
Mexico In-Vitro Diagnostics Market Growth:
The market inclines due to the growth of healthcare expenditure in the emerging markets, the high demand for advanced testing methods, and rise in global GDP per capita and growing geriatric population are the factors influencing the growth of the market.
Mexico In-Vitro Diagnostics Industry Analysis:
Application, product divide the market, and service, end user and technology. By application, it is categorised into diabetes, cancer, cardiology, autoimmune disease, drug testing, infectious disease, and nephrology. By the end-user market is segmented into hospitals, laboratories, point care testing, patient-care testing and academic industries. By technology, the market is into the immune disease, clinical chemistry, molecular diagnostics, Clinical microbiology, haematology, coagulation, and hemostasis by product the market is categorised into reagents and kits, instruments, consumables and data management services. By reusability, the market is segmented into reusable IVD devices and disposable IVD devices.
Mexico In-Vitro Diagnostics Market Outlook:
In-vitro means study of microorganisms, cells, biological molecules outside their biological context called test tube experiments. These diagnostics use analytical instruments and reagents on specific samples. North America is the leading one in the In-vitro diagnostics market.
Mexico In-Vitro Diagnostics Market Trends:
Danaher signed to acquire Cepheid for $ 4 billion and acquired Phenomenex for $ 700 million to expand in life sciences space. Siemens signed to acquire Mentor Graphics Corporation. Abbott announced that it had completed the acquisition of St. Jude Medical, Inc., the company as a leader in medical device arena.
Mexico In-Vitro Diagnostics Market Research Reports Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott Laboratories
- Danaher
- Siemens Healthcare
- Becton, Dickinson & Company
- Thermo Fisher Scientific
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 Immunochemistry
6.3 Molecular diagnostics
6.4 Clinical chemistry
6.5 Clinical Microbiology
6.6 Hematology
6.7 Coagulation and Hemostasis
Chapter 7 Market Segmentation by Product & Service
7.1 Introduction
7.2 Reagents & kits
7.3 Data management software services
7.4 Instruments
7.5 Consumables
Chapter 8 Market Segmentation by End-user
8.1 Introduction
8.2 Hospitals
8.3 Laboratories
8.4 Patient self-testing
8.5 Academic institutes
8.6 Point-care testing
Chapter 9 Market Segmentation by Application
9.1 Introduction
9.2 Diabetes
9.3 Cancer
9.4 Cardiology
9.5 Drug testing
9.6 Autoimmune disease
9.7 Nephrology
9.8 Infectious disease
Chapter 10 Market Segmentation by Usability
10.1 Disposable IVD devices
10.2 Reusable IVD devices
Chapter 11 Market Segmentation by Geography
11.1 Mexico
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 Thermo Fisher scientific
13.2 Abbott Laboratories
13.3 Danaher
13.4 Siemens Healthineers
13.5 Becton, Dickinson & Company
13.6 Biomrieux SA
13.7 Life scan, Inc.
13.8 Roche
13.9 Sysmex Corporation
13.10 DiaSorin S.p.A
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,027.60 - €6,758.66
- INR: ₹180,299.68 - ₹600,998.93
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,736.03 - £5,786.76
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
An in-vitro diagnostic is a process where diagnostic tests performed using analytical instruments and reagents on specific samples such as blood, urine, and other body fluids. The samples are gathered from patients or healthy individuals to identify and detect the diseases. The market is valued at USD XX billion in 2017 and is projected to USD XX billion by 2024 at a CAGR of 5.8%.
Mexico In-Vitro Diagnostics Market Share:
IVD plays a vital role in early diagnostics and detection of diseases. The point of care testing segment is holding the most significant share in the market at present.
Mexico In-Vitro Diagnostics Market Size:
North America is the leading one, and Mexico is expected to grow and dominate in forecast due to increasing acceptance of personalised medicine and growing adoption of advanced products and increase in chronic diseases patient pool and technological advancements. Asia-Pacific is expected to have highest CAGR during forecast due to growth in research and increasing investments.
Mexico In-Vitro Diagnostics Market Growth:
The market inclines due to the growth of healthcare expenditure in the emerging markets, the high demand for advanced testing methods, and rise in global GDP per capita and growing geriatric population are the factors influencing the growth of the market.
Mexico In-Vitro Diagnostics Industry Analysis:
Application, product divide the market, and service, end user and technology. By application, it is categorised into diabetes, cancer, cardiology, autoimmune disease, drug testing, infectious disease, and nephrology. By the end-user market is segmented into hospitals, laboratories, point care testing, patient-care testing and academic industries. By technology, the market is into the immune disease, clinical chemistry, molecular diagnostics, Clinical microbiology, haematology, coagulation, and hemostasis by product the market is categorised into reagents and kits, instruments, consumables and data management services. By reusability, the market is segmented into reusable IVD devices and disposable IVD devices.
Mexico In-Vitro Diagnostics Market Outlook:
In-vitro means study of microorganisms, cells, biological molecules outside their biological context called test tube experiments. These diagnostics use analytical instruments and reagents on specific samples. North America is the leading one in the In-vitro diagnostics market.
Mexico In-Vitro Diagnostics Market Trends:
Danaher signed to acquire Cepheid for $ 4 billion and acquired Phenomenex for $ 700 million to expand in life sciences space. Siemens signed to acquire Mentor Graphics Corporation. Abbott announced that it had completed the acquisition of St. Jude Medical, Inc., the company as a leader in medical device arena.
Mexico In-Vitro Diagnostics Market Research Reports Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott Laboratories
- Danaher
- Siemens Healthcare
- Becton, Dickinson & Company
- Thermo Fisher Scientific
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 Immunochemistry
6.3 Molecular diagnostics
6.4 Clinical chemistry
6.5 Clinical Microbiology
6.6 Hematology
6.7 Coagulation and Hemostasis
Chapter 7 Market Segmentation by Product & Service
7.1 Introduction
7.2 Reagents & kits
7.3 Data management software services
7.4 Instruments
7.5 Consumables
Chapter 8 Market Segmentation by End-user
8.1 Introduction
8.2 Hospitals
8.3 Laboratories
8.4 Patient self-testing
8.5 Academic institutes
8.6 Point-care testing
Chapter 9 Market Segmentation by Application
9.1 Introduction
9.2 Diabetes
9.3 Cancer
9.4 Cardiology
9.5 Drug testing
9.6 Autoimmune disease
9.7 Nephrology
9.8 Infectious disease
Chapter 10 Market Segmentation by Usability
10.1 Disposable IVD devices
10.2 Reusable IVD devices
Chapter 11 Market Segmentation by Geography
11.1 Mexico
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 Thermo Fisher scientific
13.2 Abbott Laboratories
13.3 Danaher
13.4 Siemens Healthineers
13.5 Becton, Dickinson & Company
13.6 Biomrieux SA
13.7 Life scan, Inc.
13.8 Roche
13.9 Sysmex Corporation
13.10 DiaSorin S.p.A
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.